Biology subjects

Parhizkar, S.

Publications and source records attributed to Parhizkar, S..

4 recordsLinked to original sources

bioRxiv2026

Chronic Sleep Disruption Activates the Transcriptional Unfolded Protein Response and Induces Compartment-Specific Proteomic Changes in Mice

Sleep disruption (SD) is associated with adverse brain health and increased risk of dementia, including Alzheimer's disease (AD), yet the pathological mechanisms underlying this association are not fully understood. Preclinical studies have shown that acute SD impairs cognition by altering vulnerable synapses (molecular composition, ultrastructure, and function). However, the cumulative effects of chronic SD on the adult brain and its vulnerable synapses, that might contribute to AD risk, remain poorly defined. Here, we investigated the impact of chronic SD on brain transcriptomic signatures and subcellular compartment-specific proteomic profiles to identify genes, proteins, and signaling pathways that might confer AD risk. Chronic SD induced a modest transcriptional stress response globally, whereas alterations were more pronounced in the synaptosomal (synapse-enriched P2 fractions) and whole-brain proteomes. Remarkably, chronic SD elicited unique proteomic alterations at the synaptic compartment were distinct from whole-brain effects, including increased proteins involved in synaptic vesicle endocytosis, regulation of dendritic spine morphogenesis, and regulation of long-term synaptic depression, compared to increased proteins involved in immune/inflammatory, glial responses and neuronal function at the whole-brain level. Consistent with the chronic SD-induced molecular signatures, we observed subtle ultrastructural changes in vulnerable CA1 hippocampal synapses, including reduced pre-synapse size and decreased synaptic vesicle density, which suggest that chronic SD modifies synaptic transmission and plasticity. Together, our findings indicate that chronic SD differentially impacts the brain and the synaptic proteome, nominating candidate therapeutic targets and signaling pathways for future mechanistic studies of chronic SD and how SD contributes to increased AD risk.

neuroscience↗

bioRxiv2026

APOE4 reduction in vascular-associated fibroblasts decreases cerebral amyloid angiopathy and associated vascular dysfunction

Cerebral amyloid angiopathy (CAA), characterized by cerebrovascular amyloid deposition, is strongly associated with Alzheimers disease, ischemic injury, and lobar hemorrhages. APOE4 is the strongest known genetic risk factor for CAA, yet the cellular sources of APOE4 that drive pathogenic vascular amyloid deposition remain poorly defined. Here, we identify vascular-associated fibroblasts (VAFs) as a key source of APOE4 that mediates CAA and cerebrovascular dysfunction. In post-mortem brain tissue from APOE4/E4 patients with confirmed CAA, APOE colocalizes with COL6 VAFs around A{beta}-laden vessels. Therefore, to study the contribution of APOE4 derived from VAFs in CAA, independently of parenchymal sources, we used 5xFAD mice in which the endogenous mouse Apoe coding exons are replaced with floxed human APOE4 sequences. This enables selective suppression of APOE4 expression in VAFs upon tamoxifen induction of Col1a2-CreERT+. APOE4 reduction in VAFs markedly reduced CAA, with the strongest effects observed in leptomeningeal vessels. Additionally, A{beta}40, which preferentially associates with vascular amyloid, was significantly reduced in the vascular fraction. VAF APOE4 depletion resulted in fewer small microbleeds and an approximately 50% reduction in parenchymal border macrophages within the leptomeningeal compartment, whereas astrocytic reactivity remained unchanged. Functional assessment using in vivo multi-parametric photoacoustic microscopy revealed improved arterial dilation and blood flow in amyloid-laden leptomeningeal arteries. Together, these findings establish VAF-derived APOE4 as a compartment-specific driver of CAA and cerebrovascular dysfunction. One Sentence SummaryVascular-associated fibroblasts are a major source of pathogenic APOE4 that drives vascular dysfunction in cerebral amyloid angiopathy.

neuroscience↗

bioRxiv2020

Microbiota-derived short chain fatty acids promote Aβ plaque deposition

Previous studies have identified a crucial role of the gut microbiome in modifying Alzheimers disease (AD) progression. However, the mechanisms of microbiome-brain interaction in AD, including the microbial mediators and their cellular targets in the brain, were so far unknown. Here, we identify microbiota-derived short chain fatty acids (SCFA) as key metabolites along the gut-brain axis in AD. Germ-free (GF) AD mice exhibit a substantially reduced A{beta} plaque load and markedly reduced SCFA plasma concentrations; conversely, SCFA supplementation to GF AD mice was sufficient to increase the A{beta} plaque load to levels of conventionally colonized animals. While A{beta} generation was only mildly affected, we observed strong microglial activation and upregulation of ApoE upon the SCFA supplementation. Taken together, our results demonstrate that microbiota-derived SCFA are the key mediators along the gut-brain axis resulting in increased microglial activation, ApoE upregulation and A{beta} deposition.

neuroscience↗

bioRxiv2020

The Alzheimer's disease-associated protective Plcγ2-P522R variant promotes beneficial microglial functions

BackgroundMicroglia-specific genetic variants are enriched in several neurodegenerative diseases, including Alzheimers disease (AD), implicating a central role for alterations of the innate immune system in the disease etiology. A rare coding variant in the PLCG2 gene (rs72824905, p.P522R) selectively expressed in microglia and macrophages was recently identified and shown to reduce the risk for AD. MethodsTo assess the role of this variant in the context of immune cell functions, we generated a Plc{gamma}2-P522R knock-in (KI) mouse model using CRISPR/Cas9 gene editing. ResultsFunctional analyses of macrophages derived from homozygous KI mice and wild type (WT) littermates revealed that the P522R variant potentiates the primary function of Plc{gamma}2 as a Pip2-metabolizing enzyme. This was associated with improved survival, enhanced phagocytic activity, and increased acute inflammatory response of the KI cells. Enhanced phagocytosis was also observed in mouse BV2 microglia-like cells overexpressing human PLC{gamma}2-P522R, but not in PLC{gamma}2-WT expressing cells. Furthermore, the brain mRNA signature together with microglia-specific PET imaging indicated microglia activation in Plc{gamma}2-P522R KI mice. ConclusionThus, we have delineated cellular mechanisms of the protective Plc{gamma}2-P522R variant, which provide further support for the emerging idea that activated microglia exert protective functions in AD.

neuroscience↗